Evidence map›Paper›PMID 38818472›Full record

ArticleInternational journal of medical sciences2024

A Dynamic Prediction Model for Renal Progression in Primary Membranous Nephropathy.

Yufeng Liang, Qiu Li, Zhenhuan Zou, Binsan Huang, Nan Zhong, Chenlun Li, Azhen Wang, Yongping Chen, Shuzhen Tu, Jianxin Wan

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of medical sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Yufeng LiangDepartment of Nephrology, Blood Purification Research Center, The First Affiliated Hospital, Fujian Medical University, Fuzhou 350005, China.
Qiu LiDepartment of Nephrology, The Second Hospital of Longyan, Fujian 364000, China.
Zhenhuan ZouDepartment of Nephrology, Blood Purification Research Center, The First Affiliated Hospital, Fujian Medical University, Fuzhou 350005, China.
Binsan HuangDepartment of Nephrology, The Second Hospital of Longyan, Fujian 364000, China.
Nan ZhongDepartment of Orthopedics, The Second Hospital of Longyan, Fujian 364000, China.
Chenlun LiDepartment of Nephrology, The Second Hospital of Longyan, Fujian 364000, China.
Azhen WangDepartment of Nephrology, The Second Hospital of Longyan, Fujian 364000, China.
Yongping ChenDepartment of Nephrology, The Second Hospital of Longyan, Fujian 364000, China.
Shuzhen TuSchool of Mathematics and Information Engineering, Longyan University, Fujian, 364000, China.
Jianxin WanDepartment of Nephrology, Blood Purification Research Center, The First Affiliated Hospital, Fujian Medical University, Fuzhou 350005, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Disease ProgressionGlomerular Filtration RateGlomerulonephritis, MembranousAdultFemaleHumansKidneyKidney Failure, ChronicMaleMiddle AgedPrognosisProteinuriaReceptors, Phospholipase A2Retrospective StudiesRisk FactorsROC CurvePLA2R1 protein, humanReceptors, Phospholipase A2dynamicnomogramprediction modelprimary membranous nephropathyrenal progression.web-based

Identifiers

PMID38818472
PMCPMC11134588

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.